Research and Development
We are dedicated to advancing plant-based medicines through rigorous scientific research. Guided by COO Bernard Pieters, we’re redefining plant-based healing, challenging opioid dependence with groundbreaking research in cannabis and psilocybin. Our goal: forging powerful, natural therapies in response to shifting global attitudes for safer, non-addictive medicinal alternatives.
Unlocking the Potential of Psilocybin
Medical psychedelic research has undergone a renaissance in recent years. Psilocybin is a naturally occurring compound found in certain mushrooms that is structurally similar to the human neurotransmitter serotonin, which regulates mood and perception.
Early clinical trials show when administered in controlled settings with psychological support, psilocybin may be a safe and effective treatment for mental health disorders like depression, PTSD, and anxiety. With over 20 years experience leading cannabis innovations, Bernard is now spearheading efforts to streamline commercial psilocybin cultivation and extraction for medicinal use.
Establishing Cannabis as a Trusted Treatment
Through the cultivation of medical cannabis strains with distinct cannabinoid and terpene compositions, we are establishing the foundation for tailored cannabis therapies that target specific symptoms and conditions with precision. We continually refine cultivars and protocols, leveraging data to improve varieties and therapeutic efficacy.
Driving Progress Through Research
Our continuous cannabis research and development efforts are dedicated to creating novel strains and exploring unique applications for rare cannabinoids. These endeavours are intended to assist therapy developers in addressing chronic illnesses.
